type here...

Latest news

Manufacturing

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Major drugmakers have announced more than $370 billion in U.S. project commitments for the next five years, according to...
Clinical

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

Bristol Myers Squibb’s hopeful late-year phase 3 rebound is no longer in the cards. The company said that the...
Commercial

Triana Biomedicines Secures $120 Million Series B to Advance Lead Molecular Glue Degrader

Triana Biomedicines has raised $120 million in a series B round that will be used to move its lead...
Commercial

Crescent Boosts Pipeline with Kelun Deal Worth $80M

Crescent Biopharma has struck a deal to pay Kelun-Biotech $80 million for ex-China license to an antibody-drug conjugate, giving...
Commercial

Regeneron and Tessera Partner to Advance TSRA-196 for Alpha-1 Antitrypsin Deficiency

Regeneron has established a global collaboration with Tessera Therapeutics...
Commercial

Protego Biopharma Secures $130M Series B to Advance PROT-001 Into Pivotal Testing

Protego Biopharma has completed an oversubscribed series B fundraise...
Clinical

Belite Bio Succeeds in Rare Eye Disease Phase 3 Trial

A phase 3 study of Belite Bio’s tinlarebant in adolescents with an uncommon inherited eye disorder has achieved its...
Regulatory

FDA Grants Clearance for Ceribell’s Clarity Algorithm to Detect Electrographic Seizures Across All Age Groups

FDA Grants Ceribell has received 510(k) clearance from the U.S. Food and Drug Administration for its updated Clarity algorithm,...
Commercial

With FDA approval, AstraZeneca’s Imfinzi extends its perioperative expertise to early-stage stomach cancer

 Imfinzi by AstraZeneca is already on the list of achievements in the category of perioperative labels, and the new...
Clinical

Novo Advances Amycretin Into Phase 3 Development for Type 2 Diabetes

Novo Advances Amycretin ;Novo Nordisk is moving ahead with...
Manufacturing

Novartis Plans 550 Layoffs in Switzerland While Expanding U.S. Manufacturing Footprint

 550 Layoffs ;Novartis has outlined several updates to its...
Regulatory

Novartis Gets FDA Green Light For Muscle Disorder Therapy

 FDA Green Light  ;Novartis has secured FDA approval for Itvisma, an updated version of its gene therapy Zolgensma, extending...
Clinical

Contineum, J&J Drug Shows Poor Results in Multiple Sclerosis Trial

  J&J has faced a setback in its collaboration with Contineum after their MS drug failed to show visual improvement...
Clinical

J&J Ends Phase 2 Alzheimer’s Study After Posdinemab Fails to Slow Decline

J&J has discontinued a phase 2 study assessing its Alzheimer’s disease candidate posdinemab after an interim evaluation showed the...
Regulatory

Medtronic Receives Full FDA Approval for Deep Brain Stimulation Systems for Dystonia

Medtronic's Milestone Approval Medtronic has received full approval from the...
Editotial Team -
Brand & Marketing

UniQure sells hemophilia gene therapy royalty rights

UniQure made an announcement that it has sold a...
Commercial

Edwards acquires 2 firms in deals totaling $1.2 billion

The acquisitions by Edwards of JenaValve Technology and Endotronics...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Medtronic Receives Full FDA Approval for Deep Brain Stimulation Systems for Dystonia

Medtronic's Milestone Approval Medtronic has received full approval from the...
Editotial Team -
Clinical

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

Bristol Myers Squibb’s hopeful late-year phase 3 rebound is...
Commercial

Triana Biomedicines Secures $120 Million Series B to Advance Lead Molecular Glue Degrader

Triana Biomedicines has raised $120 million in a series...
Commercial

Crescent Boosts Pipeline with Kelun Deal Worth $80M

Crescent Biopharma has struck a deal to pay Kelun-Biotech...
Regulatory

Medtronic Receives Full FDA Approval for Deep Brain Stimulation Systems for Dystonia

Medtronic's Milestone Approval Medtronic has received full approval from the...

Research & Development

Market Access

Manufacturing

Eli Lilly to Invest $5 Billion in Virginia API Plant, First of Four New U.S. Manufacturing Mega Sites

Eli Lilly and Company has announced a $5 billion...
Manufacturing

AC Immune Cuts Workforce and Refocuses Pipeline to Extend Cash Runway

AC Immune is reducing its workforce by about 30%...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Editor Picks

Must Read

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice